Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Calcifediol Anhydrous. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VDR known ✓ | P11473 | 8/20 | 0.82 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | SREBF1 | P36956 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.82 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.82 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.82 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.82 |
| ▸ | PGR | P06401 | 2/20 | 0.82 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.82 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.82 |
| ▸ | CDC25A | P30304 | 1/20 | 0.82 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.82 |
| ▸ | HPGD | P15428 | 1/20 | 0.82 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.82 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.82 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.82 |
| ▸ | DRD3 | P35462 | 1/20 | 0.82 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Calcifediol Anhydrous SCHEMBL10018928 | 1.00 | MAPT (1.00) | MAPTSMN1; SMN2SREBF1VDRMEN1 | |
| Calcifediol Anhydrous SCHEMBL13301741 | 1.00 | MAPT (1.00) | MAPTSMN1; SMN2SREBF1VDRMEN1 | |
| Calcifediol Anhydrous SCHEMBL9933434 | 1.00 | MAPT (1.00) | MAPTSMN1; SMN2SREBF1VDRMEN1 | |
| Calcifediol Anhydrous SCHEMBL24102681 | 1.00 | MAPT (1.00) | MAPTSMN1; SMN2SREBF1VDRMEN1 | |
| Calcifediol Anhydrous SCHEMBL5614025 | 1.00 | MAPT (1.00) | MAPTSMN1; SMN2SREBF1VDRMEN1 | |
| Calcifediol Anhydrous SCHEMBL24051907 | 1.00 | MAPT (1.00) | MAPTSMN1; SMN2SREBF1VDRMEN1 | |
| Calcifediol Anhydrous SCHEMBL14112503 | 1.00 | MAPT (1.00) | MAPTSMN1; SMN2SREBF1VDRMEN1 | |
| Calcifediol Anhydrous SCHEMBL24571935 | 1.00 | MAPT (1.00) | MAPTSMN1; SMN2SREBF1VDRMEN1 | |
| Calcifediol Anhydrous SCHEMBL22403256 | 1.00 | MAPT (1.00) | MAPTSMN1; SMN2SREBF1VDRMEN1 | |
| Calcifediol Anhydrous SCHEMBL12349027 | 1.00 | MAPT (1.00) | MAPTSMN1; SMN2SREBF1VDRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10718 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122084707-A | 25-Hydroxy vitamin D3Molecularly imprinted electrochemical sensor, preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20260140108-A1 | EXTRACTION ROD AND PREPARATION METHOD THEREOF, AND METHOD FOR DETECTING 25-HYDROXYVITAMIN D | INNOVATION CENTER OF YANGTZE RIVER DELTA ZJU (CN) | 2026-05-21 | — | — | US | claimed |
| US-20260139860-A1 | PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS | CENTRE FOR DIGESTIVE DISEASES (AU) | 2026-05-21 | — | — | US | claimed |
| WO-2026104734-A1 | INJECTABLE COMPOSITION OF 25-HYDROXY-VITAMIN D3 | DSM IP ASSETS B.V. (NL) | 2026-05-21 | — | — | WO | claimed |
| US-12630852-B2 | Modified sterol acyltransferases | DSM IP ASSETS B.V. (NL) | 2026-05-19 | — | — | US | claimed |
| US-12622879-B2 | Transdermal delivery formulation | TRS II, LLC (US) | 2026-05-12 | — | — | US | claimed |
| EP-3204047-B2 | CALCIFEDIOL SOFT CAPSULES | FAES FARMA SA (ES) | 2026-05-06 | — | — | EP | claimed |
| WO-2026087470-A1 | AG5 COMPOUND FOR USE IN THE TREATMENT OF FATTY LIVER DISEASES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) | 2026-04-30 | — | — | WO | claimed |
| US-20260115161-A1 | 2-HYDROXY-OCTADECENE-9-CIS-OATE FOR USE IN THE TREATMENT OF ONCOLOGICAL PATHOLOGIES AND NEUROPATHIC PAIN | LAMINAR PHARMACEUTICALS S A (ES) | 2026-04-30 | — | — | US | claimed |
| EP-4732836-A1 | AG5 COMPOUND FOR USE IN THE TREATMENT OF IN FATTY LIVER DISEASES | Consejo Superior De Investigaciones Científicas (ES) | 2026-04-29 | — | — | EP | claimed |
| EP-0177920-A2 | Pharmaceutical composition for external use containing active type vitam D3 | TEIJIN LIMITED (JP) | 1986-04-16 | — | — | EP | claimed |
| EP-0162510-A1 | Kit for use in the treatment of osteoporosis | THE PROCTER & GAMBLE COMPANY (US) | 1985-11-27 | — | — | EP | claimed |
| WO-1984004527-A1 | PROCESS FOR THE PREPARATION OF 1alpha,25-DIHYDROXYLATED VITAMIN D2 AND RELATED COMPOUNDS | WISCONSIN ALUMNI RES FOUND (US) | 1984-11-22 | — | — | WO | claimed |
| US-4481356-A | MEDICAL DIAGNOSIS | THE UPJOHN COMPANY (US) | 1984-11-06 | — | — | US | claimed |
| WO-1982004051-A1 | MIXTURE OF HYDROXYLATED VITAMIN D DERIVATIVES SUITABLE FOR PREVENTING PARTURIENT PARESIS IN DAIRY CATTLE | WISCONSIN ALUMNI RES FOUND (US) | 1982-11-25 | — | — | WO | claimed |
| US-4330537-A | PHOSPHONATE COMPOUNDS AND VITAMIN D DERIVATIVES USEFUL AGAINST OSTEOPORSIS | THE PROCTER & GAMBLE COMPANY (US) | 1982-05-18 | — | — | US | claimed |
| WO-1982000465-A1 | PROCESS FOR PREPARING VITAMIN D-LACTONES | WISCONSIN ALUMNI RES FOUND (US) | 1982-02-18 | — | — | WO | claimed |
| US-4310522-A | THICKENED EGG SHELLS COMPRISING CALCIUM SOURCE AND A HYDROXY CHOLECALCIFEROL | THE UPJOHN COMPANY (US) | 1982-01-12 | — | — | US | claimed |
| US-4230700-A | ADMINISTERING AN ORGANIC MONO- OR DIPHOSPHONATE AND A VITAMIN-D-LIKE ANTIRACHITIC COMPOUND | THE PROCTER & GAMBLE COMPANY (US) | 1980-10-28 | — | — | US | claimed |
| US-4004003-A | PROPHYLAXIS, GLUCOCORTICOIDS | THE UPJOHN COMPANY (US) | 1977-01-18 | — | — | US | claimed |